Soru

Zorluk: ZorEnd-of-Life and Palliative Care

Match each patient scenario involving advanced illness with the most appropriate next step in palliative symptom management, taking into account their underlying comorbidities.

  • A 64-year-old hospice patient with end-stage renal disease and severe metastatic bone pain requires initiation of a continuous, long-acting opioid.Initiate a fentanyl transdermal patch or methadone; avoid morphine due to the risk of accumulating neurotoxic active metabolites.
  • A 72-year-old actively dying patient with a known history of severe closed-angle glaucoma develops noisy, gurgling breathing (terminal secretions).Provide postural drainage by repositioning the patient laterally; avoid antimuscarinic agents to prevent precipitation of an acute ocular crisis.
  • A 58-year-old with advanced ovarian cancer and a complete malignant small bowel obstruction has severe colicky abdominal pain and intractable vomiting.Discontinue prokinetic agents; initiate octreotide to reduce gastrointestinal secretions along with corticosteroids to decrease peritumoral edema.
  • A 79-year-old actively dying patient with a long-standing history of Parkinson disease develops severe hyperactive delirium and aggressive behavior.Administer quetiapine or consider midazolam; avoid typical antipsychotics like haloperidol to prevent severe exacerbation of extrapyramidal symptoms.

Cevap

Match the ESRD patient to fentanyl/methadone, the glaucoma patient to repositioning (avoiding antimuscarinics), the complete bowel obstruction patient to octreotide/corticosteroids (avoiding prokinetics), and the Parkinson disease patient to quetiapine/midazolam (avoiding haloperidol).
Each correct match pairs an end-of-life symptom with the appropriate modified intervention that safely circumvents the patient's specific comorbidity-related contraindication.

Adım Adım Çözüm

1
Analyze the patient with end-stage renal disease (ESRD) requiring long-acting opioids.
Identify that hepatically cleared opioids must be used.
Accumulation of morphine's renally cleared active metabolites can cause severe opioid-induced neurotoxicity.
2
Evaluate the patient with terminal secretions and closed-angle glaucoma.
Determine that antimuscarinic agents are contraindicated.
Antimuscarinics (such as scopolamine and atropine) cause pupillary dilation, which can trigger a painful acute angle-closure glaucoma crisis.
3
Assess the patient with complete malignant bowel obstruction.
Identify that prokinetic agents must be stopped and antisecretory agents started.
Metoclopramide stimulates peristalsis against a mechanical block, risking perforation; octreotide reduces secretions and bowel distention.
4
Review the agitated patient with Parkinson disease.
Conclude that typical antipsychotics must be avoided.
Haloperidol's strong dopamine antagonism will severely exacerbate Parkinsonian symptoms; quetiapine is a safer alternative.

Anahtar Kavram

Advanced symptom management in palliative care requires careful modification of standard protocols based on patient-specific comorbidities that present absolute or relative contraindications.
Bu soruyu puanla